Skip to main content

Advertisement

Table 1 Characteristics of the kidney transplant cohort at one-month post-transplantation

From: Long term evolution of endothelial function during kidney transplantation

Characteristic N = 149
Age at transplant (years) 49 (40, 59)
Race
 White 112 (75 %)
 Black 34 (23 %)
 Other 3 (2 %)
Sex (male) 111 (74 %)
BMI 27.3 (23.5, 30.5)
Tobacco use
 Never 77 (52 %)
 Current 14 (9 %)
 Former 58 (39 %)
Pack Years 11.5 (3, 24.0)
Cardiovascular diseasea 59 (40 %)
Diabetes 56 (38 %)
Hypertension 142 (95 %)
Hyperlipidemia 83 (56 %)
Months on Dialysis pre-transplant 20.3 (6.9, 47.2)
Primary cause of end-stage renal disease
 Vascular Disease 78 (52 %)
 Glomerular Disease 31 (21 %)
 Tubulointerstitial Disease 9 (6 %)
 Cystic Disease 19 (13 %)
 Structure Disease 1 (1 %)
 Renal Neoplasia 1 (1 %)
 Other 10 (7 %)
Estimated Glomerular Filtration Rate (ml/min/m2) 58 (48, 69)
Mean Arterial Pressure (mm Hg) 95.7 (87.3, 103.7)
Induction Immunosuppression
 Alemtuzumab 134 (90 %)
 Basiliximab 14 (9 %)
 Anti-Thymocyte Globulin 1 (1 %)
Maintenance Immunosuppression
 Tacrolimus 146 (98 %)
 Mycophenolate 143 (96 %)
 Prednisone 81 (54 %)
Anti-Hypertensive Medication
 Alpha Blockers 11 (7 %)
 Beta Blockers 88 (59 %)
 Calcium Channel Blockers 77 (52 %)
 ACEb Inhibitors 4 (3 %)
 Angiotensin Receptor Blocker 4 (3 %)
 Vasodilators 6 (4 %)
Statin Therapy 29 (20 %)
Slow Graft Function 23 (16 %)
Delayed Graft Function 8 (5 %)
  1. Values expressed as median (25th, 75th percentiles) or number (percent)
  2. aCardiovascular disease includes coronary artery disease, myocardial infarction, coronary artery bypass grafting, percutaneous coronary intervention, congestive heart failure, arrhythmia, stroke, and peripheral vascular disease
  3. bAngiotensin Converting Enzyme